{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-09-03T14:26:27.317475+00:00","company":{"ticker":"DQWS","cik":1652561,"company_name":"DSwiss Inc"},"pagination":{"limit":100,"returned":1,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"ma_counterparty":[{"display_name":"Jervey Choon","detail":"acquisition","count":1,"first_seen":"2023-01-20T23:59:59+00:00","last_seen":"2023-01-20T23:59:59+00:00","evidence_fact_ids":[185288]}]},"facts":[{"fact_type":"ma_transaction","fact_key":"ba0c38fa8683c174ac9745b3a463b84126c9fa3c","cik":1652561,"ticker":"DQWS","company_name":"DSwiss Inc","filed_at":"2023-01-20T23:59:59+00:00","payload":{"action":"acquisition","closing_date":"2023-01-18","consideration_text":"USD 0.23","counterparty":"Jervey Choon","effective_date":"2023-01-18","item_codes_triggered":["2.01"]},"claim":"DSwiss Inc completed an acquisition involving Jervey Choon for USD 0.23 (closed 2023-01-18).","evidence_excerpt":"DSwiss Biotech Sdn\nBhd from a shareholder, Jervey Choon, pursuant to which DSHK acquired 100% of DSBT. As consideration thereof, DSHK agreed to make the\nproceeds payment of USD 0.23 to the shareholder. DSwiss\nBiotech Sdn Bhd primarily operates in Malaysia by supplying biotech products to their clients as set forth below: Name Business\n Description DSwiss","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-23-001963","anchor_url":"https://secwatch.observer/filing/0001493152-23-001963#claim-ba0c38fa8683c174ac9745b3a463b84126c9fa3c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1652561/000149315223001963/0001493152-23-001963-index.htm"}]}